Entero Healthcare Solutions IPO GMP History
Entero Healthcare Solutions IPO has been listed on February 16, 2024 at a listing price of ₹1228.7, against the issue price of ₹1258 — a loss of ₹29.3 (-2.33%). The GMP peaked at ₹120 on 8 February 2024 and reached a low of ₹15 on 13 February 2024. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Entero Healthcare Solutions IPO raised ₹1600 Cr. through its IPO at a price band of ₹1195 to ₹1258 per share, with a lot size of 11 shares. The IPO was open for subscription from 09 Feb 2024 to 13 Feb 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 6:31 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Feb 2024 | ₹ 15 | ▼ | 1% | — | — |
| 12 Feb 2024 | ₹ 25 | ▼ | 2% | — | — |
| 10 Feb 2024 | ₹ 70 | ▼ | 6% | — | — |
| 09 Feb 2024 | ₹ 110 | ▼ | 9% | — | — |
| 08 Feb 2024 | ₹ 120 | — | 10% | — | — |
Entero Healthcare Solutions IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 09 Feb 2024
- Close 13 Feb 2024
- Allotment 14 Feb 2024
- Refund/credit 15 Feb 2024
- Listing 16 Feb 2024
Entero Healthcare Solutions IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹1258 |
|---|---|
| GMP-based estimate (pre-listing) | ₹1273 (+1.2%) |
| Listing gain / loss | −₹29.3 per share |
| Listing date | 16 Feb, 2024 |
| Actual listing price | ₹1228.7 (-2.33%) |
Is Entero Healthcare Solutions IPO GMP reliable?
Grey market premium for Entero Healthcare Solutions IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Entero Healthcare Solutions IPO full review for a fundamentals-based assessment before making any grey market trades.
Entero Healthcare Solutions IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Entero Healthcare Solutions IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Entero Healthcare Solutions IPO
Entero Healthcare Solutions Limited was incorporated in 2018 with its registered office in Gurgaon, Haryana. As per CRISIL, it is among the top three healthcare products distributors in India by revenue in Financial Year 2022.
As per CRISIL, it also achieved the fastest scale-up among Indian healthcare products distributors, reaching Rs 25,000 million of operating income within four years of operations.
Its technology-driven platform distributes healthcare products to pharmacies, hospitals and clinics across India. Its promoters are Prabhat Agrawal, Prem Sethi and OrbiMed Asia III Mauritius.
The IPO was Rs 1,600 crore, with Rs 1,000.07 crore of fresh issue and Rs 599.93 crore of offer for sale by the promoters and other shareholders. Rs 480.00 crore was planned for working capital, Rs 237.00 crore for acquisitions and Rs 142.50 crore for repaying borrowings.
Frequently asked
What is the GMP of Entero Healthcare Solutions IPO?
The current Grey Market Premium (GMP) of Entero Healthcare Solutions IPO is ₹ 15.
What is the Kostak Price of Entero Healthcare Solutions IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Entero Healthcare Solutions IPO is not available.
What is the Subject to Sauda Price of Entero Healthcare Solutions IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Entero Healthcare Solutions IPO?
Entero Healthcare Solutions IPO listed on February 16, 2024 at ₹1228.7, against the issue price of ₹1258 — a loss of -2.33%.
How did the GMP of Entero Healthcare Solutions IPO trend before listing?
The GMP of Entero Healthcare Solutions IPO was falling in its final days before listing. The GMP peaked at ₹120 on 8 February 2024. View the day-wise table above for the complete GMP history.
Explore Entero Healthcare Solutions IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
